EDWARDS LIFESCIENCES CORP (EWL.DE) Stock Fundamental Analysis
Europe - FRA:EWL - US28176E1082 - Common Stock
72.41 EUR
-1 (-1.36%)
We assign a fundamental rating of 7 out of 10 to EWL. EWL was compared to 60 industry peers in the Health Care Equipment & Supplies industry. EWL scores excellent points on both the profitability and health parts. This is a solid base for a good stock. While showing a medium growth rate, EWL is valued expensive at the moment. These ratings would make EWL suitable for quality investing!
1. Profitability
1.1 Basic Checks
In the past year EWL was profitable.
EWL had a positive operating cash flow in the past year.
Each year in the past 5 years EWL has been profitable.
In the past 5 years EWL always reported a positive cash flow from operatings.
1.2 Ratios
EWL's Return On Assets of 30.75% is amongst the best of the industry. EWL outperforms 100.00% of its industry peers.
Looking at the Return On Equity, with a value of 39.33%, EWL belongs to the top of the industry, outperforming 98.33% of the companies in the same industry.
EWL's Return On Invested Capital of 9.25% is fine compared to the rest of the industry. EWL outperforms 78.33% of its industry peers.
The Average Return On Invested Capital over the past 3 years for EWL is above the industry average of 9.00%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 30.75% | ||
| ROE | 39.33% | ||
| ROIC | 9.25% |
ROA(3y)21.77%
ROA(5y)18.87%
ROE(3y)29.68%
ROE(5y)26.56%
ROIC(3y)12.44%
ROIC(5y)13.58%
1.3 Margins
Looking at the Profit Margin, with a value of 72.96%, EWL belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
EWL's Profit Margin has improved in the last couple of years.
The Operating Margin of EWL (27.94%) is better than 96.67% of its industry peers.
EWL's Operating Margin has been stable in the last couple of years.
Looking at the Gross Margin, with a value of 78.87%, EWL belongs to the top of the industry, outperforming 93.33% of the companies in the same industry.
EWL's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 27.94% | ||
| PM (TTM) | 72.96% | ||
| GM | 78.87% |
OM growth 3Y-5.94%
OM growth 5Y-1.04%
PM growth 3Y38.76%
PM growth 5Y26.09%
GM growth 3Y1.43%
GM growth 5Y1.33%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), EWL is creating some value.
The number of shares outstanding for EWL has been reduced compared to 1 year ago.
EWL has less shares outstanding than it did 5 years ago.
EWL has a better debt/assets ratio than last year.
2.2 Solvency
EWL has an Altman-Z score of 12.67. This indicates that EWL is financially healthy and has little risk of bankruptcy at the moment.
EWL has a better Altman-Z score (12.67) than 93.33% of its industry peers.
EWL has a debt to FCF ratio of 1.03. This is a very positive value and a sign of high solvency as it would only need 1.03 years to pay back of all of its debts.
EWL's Debt to FCF ratio of 1.03 is amongst the best of the industry. EWL outperforms 86.67% of its industry peers.
A Debt/Equity ratio of 0.06 indicates that EWL is not too dependend on debt financing.
EWL has a Debt to Equity ratio of 0.06. This is amongst the best in the industry. EWL outperforms 86.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.06 | ||
| Debt/FCF | 1.03 | ||
| Altman-Z | 12.67 |
ROIC/WACC1.07
WACC8.65%
2.3 Liquidity
EWL has a Current Ratio of 4.68. This indicates that EWL is financially healthy and has no problem in meeting its short term obligations.
EWL has a better Current ratio (4.68) than 93.33% of its industry peers.
EWL has a Quick Ratio of 3.87. This indicates that EWL is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of EWL (3.87) is better than 93.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.68 | ||
| Quick Ratio | 3.87 |
3. Growth
3.1 Past
EWL shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -3.75%.
EWL shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 7.13% yearly.
The Revenue has been growing slightly by 4.67% in the past year.
EWL shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.58% yearly.
EPS 1Y (TTM)-3.75%
EPS 3Y5.52%
EPS 5Y7.13%
EPS Q2Q%0%
Revenue 1Y (TTM)4.67%
Revenue growth 3Y1.3%
Revenue growth 5Y4.58%
Sales Q2Q%14.67%
3.2 Future
The Earnings Per Share is expected to grow by 9.38% on average over the next years. This is quite good.
The Revenue is expected to grow by 8.39% on average over the next years. This is quite good.
EPS Next Y-1.56%
EPS Next 2Y4.77%
EPS Next 3Y7.22%
EPS Next 5Y9.38%
Revenue Next Year3.69%
Revenue Next 2Y6.66%
Revenue Next 3Y7.8%
Revenue Next 5Y8.39%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 32.33, which means the current valuation is very expensive for EWL.
EWL's Price/Earnings ratio is in line with the industry average.
EWL is valuated rather expensively when we compare the Price/Earnings ratio to 26.13, which is the current average of the S&P500 Index.
EWL is valuated quite expensively with a Price/Forward Earnings ratio of 28.93.
EWL's Price/Forward Earnings is on the same level as the industry average.
EWL's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 22.35.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 32.33 | ||
| Fwd PE | 28.93 |
4.2 Price Multiples
EWL's Enterprise Value to EBITDA ratio is in line with the industry average.
EWL's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 84.54 | ||
| EV/EBITDA | 25.63 |
4.3 Compensation for Growth
The excellent profitability rating of EWL may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)4.53
EPS Next 2Y4.77%
EPS Next 3Y7.22%
5. Dividend
5.1 Amount
EWL does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
FRA:EWL (11/5/2025, 7:00:00 PM)
72.41
-1 (-1.36%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners88.08%
Inst Owner ChangeN/A
Ins Owners0.16%
Ins Owner ChangeN/A
Market Cap42.51B
Revenue(TTM)5.88B
Net Income(TTM)4.15B
Analysts76.28
Price Target76.58 (5.76%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)4.25%
Min EPS beat(2)4.11%
Max EPS beat(2)4.4%
EPS beat(4)4
Avg EPS beat(4)3.37%
Min EPS beat(4)1.57%
Max EPS beat(4)4.4%
EPS beat(8)4
Avg EPS beat(8)0.66%
EPS beat(12)5
Avg EPS beat(12)0.01%
EPS beat(16)6
Avg EPS beat(16)-0.9%
Revenue beat(2)0
Avg Revenue beat(2)-1.11%
Min Revenue beat(2)-2.1%
Max Revenue beat(2)-0.12%
Revenue beat(4)0
Avg Revenue beat(4)-4.22%
Min Revenue beat(4)-13.79%
Max Revenue beat(4)-0.12%
Revenue beat(8)0
Avg Revenue beat(8)-3.15%
Revenue beat(12)1
Avg Revenue beat(12)-2.51%
Revenue beat(16)1
Avg Revenue beat(16)-2.76%
PT rev (1m)1.23%
PT rev (3m)5.44%
EPS NQ rev (1m)0.49%
EPS NQ rev (3m)0.72%
EPS NY rev (1m)0.19%
EPS NY rev (3m)0.89%
Revenue NQ rev (1m)0.13%
Revenue NQ rev (3m)0.06%
Revenue NY rev (1m)0.03%
Revenue NY rev (3m)0.26%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 32.33 | ||
| Fwd PE | 28.93 | ||
| P/S | 8.59 | ||
| P/FCF | 84.54 | ||
| P/OCF | 61.46 | ||
| P/B | 4.63 | ||
| P/tB | 6.43 | ||
| EV/EBITDA | 25.63 |
EPS(TTM)2.24
EY3.09%
EPS(NY)2.5
Fwd EY3.46%
FCF(TTM)0.86
FCFY1.18%
OCF(TTM)1.18
OCFY1.63%
SpS8.43
BVpS15.63
TBVpS11.26
PEG (NY)N/A
PEG (5Y)4.53
Graham Number28.07
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 30.75% | ||
| ROE | 39.33% | ||
| ROCE | 13.14% | ||
| ROIC | 9.25% | ||
| ROICexc | 13.94% | ||
| ROICexgc | 22.05% | ||
| OM | 27.94% | ||
| PM (TTM) | 72.96% | ||
| GM | 78.87% | ||
| FCFM | 10.17% |
ROA(3y)21.77%
ROA(5y)18.87%
ROE(3y)29.68%
ROE(5y)26.56%
ROIC(3y)12.44%
ROIC(5y)13.58%
ROICexc(3y)16.13%
ROICexc(5y)17.4%
ROICexgc(3y)22.87%
ROICexgc(5y)24.4%
ROCE(3y)17.66%
ROCE(5y)19.29%
ROICexgc growth 3Y-5.47%
ROICexgc growth 5Y-8.01%
ROICexc growth 3Y-11.82%
ROICexc growth 5Y-8.6%
OM growth 3Y-5.94%
OM growth 5Y-1.04%
PM growth 3Y38.76%
PM growth 5Y26.09%
GM growth 3Y1.43%
GM growth 5Y1.33%
F-Score7
Asset Turnover0.42
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.06 | ||
| Debt/FCF | 1.03 | ||
| Debt/EBITDA | 0.34 | ||
| Cap/Depr | 142.95% | ||
| Cap/Sales | 3.82% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 45.68% | ||
| Profit Quality | 13.93% | ||
| Current Ratio | 4.68 | ||
| Quick Ratio | 3.87 | ||
| Altman-Z | 12.67 |
F-Score7
WACC8.65%
ROIC/WACC1.07
Cap/Depr(3y)185.14%
Cap/Depr(5y)236.01%
Cap/Sales(3y)5.48%
Cap/Sales(5y)6.41%
Profit Quality(3y)37.92%
Profit Quality(5y)57.13%
High Growth Momentum
Growth
EPS 1Y (TTM)-3.75%
EPS 3Y5.52%
EPS 5Y7.13%
EPS Q2Q%0%
EPS Next Y-1.56%
EPS Next 2Y4.77%
EPS Next 3Y7.22%
EPS Next 5Y9.38%
Revenue 1Y (TTM)4.67%
Revenue growth 3Y1.3%
Revenue growth 5Y4.58%
Sales Q2Q%14.67%
Revenue Next Year3.69%
Revenue Next 2Y6.66%
Revenue Next 3Y7.8%
Revenue Next 5Y8.39%
EBIT growth 1Y0.21%
EBIT growth 3Y-4.72%
EBIT growth 5Y3.49%
EBIT Next Year10.47%
EBIT Next 3Y11.73%
EBIT Next 5Y12.05%
FCF growth 1Y-15.26%
FCF growth 3Y-42.99%
FCF growth 5Y-22.01%
OCF growth 1Y-15.47%
OCF growth 3Y-32.1%
OCF growth 5Y-14.39%
EDWARDS LIFESCIENCES CORP / EWL.DE FAQ
Can you provide the ChartMill fundamental rating for EDWARDS LIFESCIENCES CORP?
ChartMill assigns a fundamental rating of 7 / 10 to EWL.DE.
Can you provide the valuation status for EDWARDS LIFESCIENCES CORP?
ChartMill assigns a valuation rating of 2 / 10 to EDWARDS LIFESCIENCES CORP (EWL.DE). This can be considered as Overvalued.
What is the profitability of EWL stock?
EDWARDS LIFESCIENCES CORP (EWL.DE) has a profitability rating of 8 / 10.
What is the valuation of EDWARDS LIFESCIENCES CORP based on its PE and PB ratios?
The Price/Earnings (PE) ratio for EDWARDS LIFESCIENCES CORP (EWL.DE) is 32.33 and the Price/Book (PB) ratio is 4.63.
How financially healthy is EDWARDS LIFESCIENCES CORP?
The financial health rating of EDWARDS LIFESCIENCES CORP (EWL.DE) is 10 / 10.